Please provide your email address to receive an email when new articles are posted on . Improving diversity in cancer clinical trial enrollment has become an increased priority among oncology ...

Nearly all patients with brain metastases have limited eligibility to participate in most clinical trials. This restriction of access will hinder the systemic therapy improvements needed for all ...

“For instance, HIV positivity, as well as hepatitis B and C positivity, were commonly cited exclusion criteria despite limited evidence that these criteria significantly impact clinical outcomes,” ...

A team of investigators looked at possible dementia clinical trial requirements that could exclude people based on race and ethnicity. Overall, 82% of the trials they examined had criteria that ...

The guidances released by the FDA to expand inclusion criteria for cancer clinical trials is a step in the right direction, said Katie Goodman, RN, BSN, CCRP, director of clinical research, Florida ...

In research presented at the 61st American Society of Hematology Annual Meeting and Exposition, Abby Statler, PhD, MPH, MA, research associate, Cleveland Clinic, and her colleagues found that African ...

The primary purposes of eligibility criteria are to protect the safety of trial participants and define the trial population. Excessive or overly restrictive eligibility criteria can slow trial ...

Doctor showing clipboard to patient Renal cell carcinoma trials conducted in the past 10 years used exclusion criteria deemed potentially excessive by ASCO and FCR. Renal cell carcinoma (RCC) trials ...

Roughly 70 to 80% of ovarian cancer cases are diagnosed at an advanced stage,1 where treatment options are limited and ...